Marcus Williams is reviewing the BEACON-1 participant charts alongside Jennifer Rodriguez during a routine monitoring visit at Riverside Medical Center in Columbus, Ohio. Jennifer has been reviewing Visit 5 data for six participants, and she stops at Participant 031's chart.
"Marcus, I am marking this as a protocol deviation," Jennifer says. "Visit 5 was scheduled for Day 56, and the participant came in on Day 61. The visit window is plus or minus three days. Day 61 is five days late."
Marcus feels the familiar tightness in his chest, but he has been through this before. He acknowledges first: "Let me look at that with you." He pulls the protocol -- not from memory, but the physical document -- and turns to Section 6.2.
"Jennifer, look at Amendment 3, Section 6.2, paragraph two. The amendment extended the Visit 5 window from plus or minus three days to plus or minus seven days for participants who experienced a dose delay. Participant 031 had a two-week dose delay after the Grade 2 rash in Cycle 3. Under the amended window, Day 61 is within range."
Jennifer reviews the amendment language. She agrees the window was extended for dose-delayed participants, but she is working from a monitoring checklist that still reflects the original three-day window. "My checklist has not been updated for Amendment 3," she says. "But I need to verify that the dose delay documentation supports applying the extended window."
Marcus pulls the deviation report documenting the dose delay and the investigator's decision to extend the dosing interval. The dates align. Jennifer reviews it carefully, then nods. "The documentation supports it. I will update my checklist and note in my report that this is within the amended window. No deviation."
But then Jennifer raises a second concern: "For Participant 027, though, I see the same visit timing -- Day 60 -- but there is no dose delay documented. If the extended window only applies to dose-delayed participants, this one does not qualify."
Marcus reviews Participant 027's chart. Jennifer is right. There is no documented dose delay. The visit was two days outside the original window with no basis for applying the amended extension. Marcus nods. "You are correct on 027. That is a valid finding, and I will bring it to the investigator for discussion this afternoon."